Bio Break: Finding the Path to MedTech Innovation with the Pathfinder Program

Laboratory Developed Tests vs. In Vitro Diagnostics
Resources

Bio Break: Finding the Path to MedTech Innovation with the Pathfinder Program

Authors: Nick Allan
Topic: Bio Break

Pathfinder Program MedTech Innovation

YouTube video thumbnail

In this Pathfinder Program MedTech Innovation episode of Bio Break, Nick Allan and Joris explore one of the most dynamic early-phase services at StarFish Medical: the Pathfinder Program. If you’re a medtech innovator with a promising concept or prototype, Pathfinder helps you identify the right path forward—before you invest millions in development.

Nick explains that Pathfinder projects focus on structured, interdisciplinary exploration to de-risk early innovation decisions. Whether it’s a new diagnostic platform or a novel therapeutic device, these short, intensive engagements are designed to define your target product profile, investigate regulatory and IP strategy, and uncover unmet user needs—all before a single part is manufactured.

The episode discusses how the Pathfinder team collaborates across human factors, industrial design, systems engineering, and sometimes even early prototyping to assess feasibility and market alignment. The outcome? A comprehensive Pathfinder Report. This document helps clients understand competitive positioning, reimbursement potential, freedom to operate, and how to prioritize the product’s unique value in the clinical space.

Joris and Nick also reflect on how Pathfinder enables clients to avoid costly pivots later in the process. By bringing in industrial designers and regulatory experts early, teams can explore device form factor, usability constraints, and even conduct basic visualizations or 3D-printed proofs-of-concept.

Whether you’re preparing for a funding round, seeking to understand your market fit, or building a go-to-market strategy, the Pathfinder Program can give your team clarity and confidence. Tune in to see how this process sets the foundation for successful medical device commercialization—and why it’s one of the most rewarding project types at StarFish.

Learn more about StarFish Medical.

Diagram showing medical device at the center connected to clinicians, patients, and regulatory bodies with text 'Who are we designing for?' highlighting stakeholder mapping in MedTech design.

Understanding Medical Device Stakeholders

Every phase of a device’s life cycle involves different people with distinct needs—from clinicians and patients to service technicians and regulatory bodies.

A fluorescent protein assay sample glows under UV light as part of medical device cleaning validation testing.

Fluorescent Protein Assay Testing in Medical Devices

Nick Allan and Nigel Syrotuck explain how a fluorescent protein assay helps engineers measure contamination and cleaning performance in medical devices.

Engineer assembling electronic components during medical device design transfer process.

Bridging the Design-to-Manufacturing Gap in Medical Devices

Your team is ready for design validation. The prototype performs well, test plans are in motion, and everything points to a smooth handoff to manufacturing. Then your partner calls with bad news: they can’t build the device as designed.

Contract Manufacturer Rejection - Engineering team reviews early-stage medical device design and manufacturability during a design transfer meeting at StarFish Medical.

When the CM Says No: What to Do When Your Contract Manufacturer Rejects Your Early-Stage Build

You’ve cleared the toughest engineering hurdles and proven your design works. Then, just as you prepare to scale, your contract manufacturer turns you down.